Futura Medical Live Discussion

Live Discuss Polls Ratings Documents
Page

fx2452 15 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Prior to the release of the first part of Phase 3 results, and assuming FUM continues down a positive pathway, rather than a gentle slope upwards in stock price, the Day Traders are causing a highly jagged pattern (thanks to rapid entry & exit en masse). I would guess that as soon as the Day Trading herd sense a near term bottom is reached, they’ll pile back in for more of the same. Unfortunately, this will be ongoing probably until the first Phase 3 results are out. As the risk of failure of Phase 3 trials of MED diminishes, the probability for takeover increases. I am quite confident that, assuming successful data from the first phase 3 results, a bidding war will probably result, and possibly even before hand. The ED market is a very large one. I believe that the differentiation of MED makes it a potential game-changing product. If you had problems with ED, which product would you choose?..one that you can use as part of the foreplay or a pill that you need to time just right (an hour in advance ensuring you haven’t eaten or drunk too much)? There’ll be a big appetite for this from a few of the big boys. Then add to this the fact that if FUM as an entirety is purchased, If you own the market dominating condom product (RB), would you risk a major competitor getting hold of CSD500? Death or The Promised Land all hinges on the data from part I of the Phase 3 trials. If it’s great data, I cannot imagine any Pharma would want a licensing deal. They’ll want full rights (& full profits). Plus the DermaSys delivery method could have several other uses (other than the pain portfolio). The stock is at a crazy low price for all you get with FUM. So hang in tight and try not to get too nervous with the daily volatility!

markthemango1 15 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Well said fx!

fx2452 15 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster I have to agree regarding the volatility of FUM shares: I’m quite convinced it’s down to day traders! If you read the posts especially in the other main LSE board, it is littered with messages from day traders. For these guys a month in a stock is like a few years to long term holders. They pile in on high volume when there is expectation of a potential stock moving event. Just as quickly as they went in, they leave again causing huge volatility (& nervousness) for the long term holders to bear. They like the fact that FUM has the propensity to ‘multi bag’ but they don’t have the patience or inclination to invest for the long term. So instead they ride the ‘up waves’ making them very sharp. And of course, when they sell to book their profits, you get the sharp down turn. These guys use their ‘charting’ to help time these entry & exit points. Day traders have their favourite stock lists that give a good propensity for volatility. Unfortunately, due to the quite illiquid nature of FUM stock, it makes it a perfect contender. For us long term holders, we just need to sit tight and try to ignore this extreme volatility. As I’ve mentioned before, the future of FUM lies in the chemistry of their products. I believe in this the team are very strong. They are inexperienced from a business savvy perspective, but I think they’re learning from their past mistakes. Ultimately, success or failure will come down to the chemistry. GLA & keep the faith!

ZeroV 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Maybe the rise was exaggerated based on the fact that no news was expected… this is what traders do… buy, make money and sell so no surprise really after the multiples increase in sp. Mango just has to let us know when he/ she and mates are piling back in although that will probably be obvious when the ramping posts start up again. Finally listened to the whole podcast, nothing new but good to hear it all again from the horses mouth so to speak. The FUM team actually sound quite excited. I guess the only negative that I wasn’t aware of is that there could be a need for part 2 of phase 3 trials. And knowing our luck, this would probably end up being run prior to launch for certain countries. Would have liked to have had some more questions around commercialisation, time for approval after phase 3 successs etc, what the shelf life (!) is of the product etc.

like_investors 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster this fall is completely exaggerated. There are many panic sales. I hope there is a rebound.

markthemango1 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster I think it will do this a lot throughout the year, I’m staying patient at the moment. I’ve no doubt we’ll have another rise soon when people are expecting a TPR announcement and then later in the year getting towards phase 3 results. I’m sure this will bounce back again sometime soon and maybe go even higher.

MRLOLOL 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Result of no news from R&D day thats why it went up in price as people expected something, not sure why

Lastemporer 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster No idea why this has fallen off it’s little perch in the last two days… Am I missing something?

Ecologist 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster I like to spread my eggs among different sectors as well as stocks. Not a straight recommendation but take a look at Bushveld (BMN) who mine vanadium and Hurricane (HUR) who are soon to pump first oil from offshore Shetlands. I hold both and they are crackers. Much less risky than FUM (which has been a right disappointing cow for a number of years!) But in all things stockmarket, do your own research. I am only a (retired) Ecologist. Eco

Ecologist 14 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster We are only 6 weeks into 2019 and last week when FUM was in the low 20s this represented a threefold increase in sp in 2019. Little wonder people took some profits. Lombard have sold a couple of % of their holdings … enough to cause the pull back. Don’t worry and don’t be too greedy! Eco

like_investors 13 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster at Bernstein.babe Do you have another stock with the same huge potential as FUM and AMYT? I think stocks with Phase 3 data like this are the most promising investments. I’d like to spread my Investments.

MRLOLOL 13 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Market was probably expecting news from the R&D day but got none. Will be a wait till end of year now why I imagine its dropped. I sold my shares will buy back in if we see under 14p

like_investors 13 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster what’s the reason for this drop?

Venicebar 12 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Just spotted a podcast of yesterdays R&D seminar on MED2005 on the FUM website. An E.D. expert gives the thumbs up for the product, ( I missed his name). Check it out.

bernstein.babe 11 Feb 2019

Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster fum and amyt the hottest and cheapest biotechs both have same valuation of 44 million , both have approved drugs and both awaiting Phase 3 readout for their potential blockbuster in this year. Amyt has the better management with shire founder harry stratford as chairman on board , TOP PICKS 2019

Page